Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | -1,917 | 11,992 | 13,594 | 12,606 | 13,573 |
| Gross Profit | -1,917 | 11,992 | 13,594 | 12,606 | 13,573 |
| Operating Expenses | 137,975 | 143,099 | 145,928 | 124,564 | 123,660 |
| Operating Income | -139,892 | -131,107 | -132,334 | -111,958 | -110,087 |
| Other Income | 7,731 | 8,883 | 8,653 | 8,832 | -3,320 |
| Pre-tax Income | -132,161 | -122,224 | -123,681 | -103,126 | -113,407 |
| Net Income Continuous | -132,161 | -122,224 | -123,681 | -103,126 | -113,407 |
| Net Income | $-132,161 | $-122,224 | $-123,681 | $-103,126 | $-113,407 |
| EPS Basic Total Ops | -1.46 | -1.38 | -1.40 | -1.17 | -1.40 |
| EPS Basic Continuous Ops | -1.46 | -1.38 | -1.40 | -1.17 | -1.40 |
| EPS Diluted Total Ops | -1.46 | -1.38 | -1.40 | -1.17 | -1.40 |
| EPS Diluted Continuous Ops | -1.46 | -1.38 | -1.40 | -1.17 | -1.40 |
| EBITDA(a) | $-137,426 | $-128,817 | $-130,164 | $-109,908 | $-108,056 |